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Abstract
GRP94 is an inducible resident endoplasmic reticulum/sarcoplasmic reticulum (ER/SR) glycoprotein that functions as a
protein chaperone and Ca2 regulator. GRP94 has been reported to be a substrate for protein kinase CK2 in vitro, although
its phosphorylation in intact cells remains unreported. In Sf21 insect cells, overexpression of canine GRP94 led to the
appearance of a multiplet of three or more molecular-mass isoforms which was reduced to a single mobility form following
treatment of cells with tunicamycin, suggesting stable accumulations of consecutively modified protein. Metabolic labeling of
Sf21 cells with 32Pi led to a constitutive phosphorylation of GRP94 which, based upon phosphopeptide mapping, occurred
specifically on CK2-sensitive sites. Among the GRP94 multiplet, however, only the lowest mobility form of GRP94 was
phosphorylated, even though in vitro phosphorylation of GRP94 by CK2 led to phosphorylation of all glycosylated forms.
The 32Pi incorporation into GRP94 indicated a slow turnover of phosphate incorporation that was unaffected by inhibition
of biosynthesis, resulting in a steady-state level of phospho-GRP94 on CK2 sites. These data support a role for protein kinase
CK2 in the cell biology for GRP94 and other resident ER/SR proteins that may occur in ER compartments. ß 2000
Elsevier Science B.V. All rights reserved.
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1. Introduction
GRP94 is an abundant glycoprotein present in the
lumens of ER and SR [1^6] that exhibits chaperone-
like activity [5,7,8], and may play a role in regulating
intracellular Ca2 [9^11]. Like several resident ER/
SR proteins, GRP94 is actively retained within ER
compartments by a carboxy-terminal tetrapeptide se-
quence (^KDEL) [2,3,12] and its corresponding pro-
tein receptor [13]. In spite of this retention mecha-
nism, GRP94 can be present on the cell surface
under some conditions which are not yet understood
[14,15]. In this regard, GRP94 has been shown to act
as a receptacle for cell surface antigens which can be
used for immunotherapy of certain tumors [16]. Fur-
thermore, GRP94 can be induced to elevated levels
of expression by many cellular stresses [1,5,17], a
feature which might also lead to altered retention
[15]. Induction of GRP94 involves a nuclear signal
resulting from the presence of malfolded protein in
the ER [18,19], although additional mechanisms are
likely to exist [5,11,20,21].
GRP94 is a prominent ER and SR substrate for
protein kinase CK2 in vitro with two major sites of
phosphorylation in canine GRP94 being 285Ser and
745Ser [6]. In vitro phosphorylation of GRP94 by
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CK2 has been observed by several laboratories [6,22^
24]; however, the reaction in intact cells has yet to be
observed. GRP94 is only one of several resident SR/
ER Ca2-binding proteins that appear to be speci¢-
cally phosphorylated by this kinase in vitro [6,25^31],
suggesting that there might be some physiological
role for CK2 phosphorylation of resident ER/SR
proteins. Cardiac calsequestrin, a major resident pro-
tein of cardiac SR contains a steady-state level of
phosphate on CK2-sensitive sites following its puri-
¢cation from canine ventricular tissue [26]. We have
previously suggested that this phosphorylation reac-
tion might occur during protein movement between
cellular membrane compartments, based on the di-
vergent localization of substrate and kinase in car-
diac membrane vesicles [6,25].
GRP94 has been shown to exhibit a mass hetero-
geneity by SDS^PAGE analyses. This polymorphism
was reported both for heterologously expressed
GRP94 in COS cells [32], and for preparations of
endogenous GRP94 from mouse sarcomas [33] ; how-
ever, disagreement exists concerning the nature of the
di¡erences. Qu et al. [32] overexpressed GRP94 in
COS cells and observed two distinct mobility forms.
They concluded that there existed an all-or-none hy-
perglycosylation of GRP94 on at least three Asn res-
idues (424Asn, 460Asn, and 481Asn), with basal glyco-
sylation occurring on 196Asn. Feldweg and
Srivastava [33] reported that lower mobility forms
of GRP94 were often seen in analyses of mouse sar-
comas, but they excluded glycosylation di¡erences
based upon an apparent insensitivity to the exoglu-
cosidase N-glycanase.
In studies presented here, we have overexpressed
GRP94 in Sf21 cells using a recombinant baculovi-
rus. We found that GRP94 expression in Sf21 cells
led to the production and accumulation of multiple
distinct and stable forms that appear to di¡er only in
their extent of glycosylation. Furthermore, phos-
phorylation in situ occurs speci¢cally on a single
form of glycosylated GRP94 molecule, and only on
CK2-sensitive sites. These studies provide evidence
that GRP94 is phosphorylated by protein kinase
CK2 while in the ER, and that this protein modi¢-
cation may be closely aligned with protein processing
and glycosylation.
2. Materials and methods
2.1. Antibodies
A⁄nity-puri¢ed peptide antibodies to the N-termi-
nus (residues 1^15) of canine GRP94 were made and
used as previously described [6]. Protein concentra-
tions were determined by the method of Lowry [34].
SDS^PAGE was carried out according to Laemmli
[35]; immunoblotting according to Towbin [36], with
immunoreactivity detected by [125I]protein binding
and autoradiography [37].
2.2. Construction of GRP94 and cardiac calsequestrin
recombinant baculoviruses
Canine GRP94 and cardiac calsequestrin cDNAs
were cloned from a canine cardiac cDNA (Vgt10)
library [6,38]. The cardiac calsequestrin clone IC3A
[38] was a gift of Dr. Larry Jones, Indiana University
School of Medicine. The cDNA inserts were sub-
cloned into the EcoRI cloning site of the baculovirus
transfer vector pVL1392, and co-transfected with Ba-
culoGold (Pharmingen) baculovirus DNA according
to manufacturer’s speci¢cations. Cell lysates, highly
enriched in recombinant virus containing the GRP94
or calsequestrin inserts were then used for plaque
puri¢cation by standard methods [39,40].
2.3. Expression of proteins in Sf21 cells
For puri¢cation of GRP94, 500 ml of Sf21 cells at
a density of 1.5U106 cells/ml were grown in suspen-
sion with GRP94 recombinant baculovirus using a
multiplicity of infection (MOI) of 5^10, as previously
described [41]. The cell suspension was incubated at
27‡C in a 4-l Erlenmeyer £ask in an orbital shaker
(90 rpm) in Grace’s medium containing 10% fetal
bovine serum, 0.1% Pluronic F68, 100 U/ml penicil-
lin, 100 Wg/ml streptomycin, and 0.25 Wg/ml ampho-
tericin B. At 2.5^3.0 days postinfection, the cells were
sedimented and stored frozen at 370‡C. For expres-
sion and metabolic labeling of GRP94 or calseques-
trin, attached Sf21 cells (3U106 cells/T75 £ask) were
infected with GRP94 recombinant virus at an MOI
of 5^10.
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2.4. Puri¢cation of GRP94 from Sf21 cells
Three 500-ml preparations of GRP94-baculovirus-
infected insect cells (1.5U106 cells/ml) were collected
by centrifugation, yielding 1700 mg protein. Cells
were resuspended in 1700 ml bu¡er containing
15 mM Tris, pH 8, 0.5 mM EGTA, 100 mM
NaCl, and 1% Triton X-100, and centrifuged at
80 000Ugmax for 1 h to remove insoluble protein.
Detergent extract was absorbed onto 100 ml
DEAE-Sephacel (Pharmacia) for 1 h at 4‡C, and
the unbound protein removed by washing the resin
in a glass column. Protein was eluted from this and
subsequent columns using an FPLC (Pharmacia)
chromatography unit. Column fractions were as-
sayed by immunoblotting with anti-GRP94 antibod-
ies, and by Stains-All staining of proteins on SDS-
gels [6,42]. A single peak of GRP94 eluted from the
DEAE-Sephacel column, and was pooled, diluted
(to reduce salt concentration) when necessary, and
subsequently chromatographed on Resource Q
(Pharmacia), phenyl-agarose (to which it selectively
does not bind), and Mono Q (Pharmacia). GRP94
was recovered in pure form after Mono Q chroma-
tography, and the protein was pooled, concentrated
using a Centricon-30 ¢lter (Amicon), and stored at
320‡C.
2.5. Metabolic labeling of GRP94 in insect cells
After 1^3 days of infection, cells were sloughed o¡
of dishes, transferred to sterile tubes and washed in
label-free medium, then incubated in suspension for
20 min using label-free medium. Cysteine and me-
thionine-free Grace’s medium (Sigma) plus supple-
ment was used for [35S]Translabel (ICN), and cus-
tom-synthesized supplemented Grace’s medium
(Gibco-BRL) was used for 32Pi-labeling. After cells
were washed, 0.5U106 cells were placed in 1.0 ml of
label-free medium containing 20 WCi Translabel or
100 WCi 32Pi, and rocked at 27‡C for 4 h. At the
end of the labeling period, cells were pelleted, the
radioactive medium removed, and cells were resus-
pended in 20 mM Tris (pH 8.0), 75 mM NaCl, 1 mM
EDTA, 10 mM NaF, 10 mM L-glycerophosphate,
and 1% Triton X-100 (bu¡er A) at 4‡C. Detergent
extracts were prepared by centrifugation at 12 000
rpmU10 min at 4‡C to remove insoluble material.
2.6. Pulse-chase experiments
Sf21 cells were pulse labeled as described, and cells
were pelleted, resuspended in standard complete
Grace’s medium, and pelleted again. For [35S]Met/
Cys labeling. The wash medium contained ¢ve times
the normal level of unlabeled methionine and cys-
teine to reduce reutilization of radiolabel. Pelleted
and washed cells were resuspended and aliquoted
to separate tubes of 0.5 ml total volume, and tubes
were again rocked for several chase times. A control
(chase time = 0) tube was processed immediately by
spinning down cells, decanting the medium, and
freezing the tube on dry ice until all chase times
were harvested. At that time, cell pellets were resus-
pended in bu¡er A and GRP94 was immunoprecipi-
tated and immune complexes analyzed.
2.7. Immunoprecipitation of GRP94
Detergent extracts (100 Wg) were added to puri¢ed
anti-GRP94 antibodies (V5 Wg) at 4‡C and incu-
bated for 90 min; 30 Wl protein A-agarose was
added, and incubated an additional 60 min. Immune
complexes were isolated by centrifugation, washed
three times in bu¡er A. Antibody and GRP94 anti-
gen were dissociated from the protein A-beads using
Laemmli (SDS) bu¡er, and samples were analyzed by
SDS^PAGE.
2.8. In vitro phosphorylation of GRP94
GRP94 immune complexes, puri¢ed GRP94, and
cardiac SR vesicles were incubated for 10 min at
30‡C in 20 mM MOPS, pH 7.5, 10 mM MgCl2, 20
WM [Q-32P]ATP, 150 mM NaCl, and 0.2% Triton X-
100, and 1 Wg puri¢ed CK2, as previously described
[26]. Protein kinase CK2 was puri¢ed from rat car-
diac tissue as previously described [27]. Phosphory-
lation was stopped by addition of SDS-containing
Laemmli sample bu¡er, and samples were analyzed
by SDS^PAGE and autoradiography.
2.9. Acid phosphatase treatment of GRP94
GRP94 (1.0 Wg) was incubated for 30 min at 30‡C
in 30 mM MES (pH 5.8), 0.1% Triton X-100, and
3 mM EGTA in the absence or presence of 0.5 U/ml
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of acid phosphatase from white potato. The minimal
e¡ective concentration of phosphatase needed was
determined in pilot dephosphorylation experiments
against CK2-[32P]phosphorylated GRP94. To per-
form subsequent phosphorylation reactions, aliquots
were diluted 10-fold into a standard phosphorylation
reaction mixture at pH 7.4.
2.10. Proteolytic phosphopeptide maps
Proteolysis of proteins using Staphylococcus aureus
protease (SAP) was performed as described by Cleve-
land et al. [43], and as previously described [27].
Brie£y, gel pieces containing [32P]radiolabeled pro-
teins were excised from a dried gel, reswollen in
Laemmli SDS solution, and electrophoresed with
0.1 U SAP in 15% acrylamide with a 6-cm-long
stacking gel. For phosphopeptide mapping with tryp-
sin and papain, gel pieces containing [32P]GRP94
were excised, reswollen and washed in 25% propanol,
10% acetic acid, then in 50% methanol. Gel pieces
were dried on a Speed-Vac (Savant), and reswollen in
300 Wl 75 mM NH4HCO3 containing 0.3 Wg of tryp-
sin or papain. Samples were incubated at 37‡C for
2 h, then vortexed, and aqueous contents were dried
by Speed-Vac, then dissolved in SDS (Laemmli) bu¡-
er and analyzed by SDS^PAGE (15% acrylamide).
Peptide-containing gels were dried without ¢xation,
and autoradiography performed.
2.11. Analysis of GRP94 glycosylation
Sf21 cells were infected with GRP94-encoding ba-
culovirus, and treated with 0, 0.05, or 0.5 Wg/ml tu-
nicamycin for 48 h. Cells were harvested, homoge-
nates were analyzed by SDS^PAGE and stained for
protein, or transferred to nitrocellulose, probed with
horseradish peroxidase-coupled concanavalin A (Con
A^HRP) (30 Wg/ml in 50 mM Tris, pH 8.0, 100 mM
NaCl), and developed with 3,3P-diaminobenzidine
(DAB) (sigmaFAST tablets, Sigma) according to
the manufacturer’s speci¢cations.
2.12. Materials
[32P]Orthophosphate, [Q-32P]ATP, and [125I]protein
A were from NEN Life Science; [35S]translabel was
from ICN Biomedical. Tunicamycin, cycloheximide,
thapsigargin, brefeldin A, nocadazole, Con A^HRP,
and DAB were from Sigma. Lactacystin and carbo-
benzoxy-L-leucyl-L-leucyl-L-leucinal (MG-132), spe-
ci¢c proteasome inhibitors, were from Calbiochem.
Geldanamycin was provided by the National Cancer
Institute, Drug Synthesis and Chemistry Branch.
Molecular mass standards were from Bio-Rad. Other
reagents were from Sigma or Fisher.
3. Results
3.1. Expression and chromatography of a GRP94
multiplet in Sf21 insect cells
Overexpression of canine GRP94 in Sf21 insect
cells by a recombinant baculovirus led to the appear-
ance of a protein multiplet of three or more molec-
ular-mass isoforms on SDS-gels (Fig. 1). Each of the
mobility forms reacted speci¢cally with anti-GRP94
anti-peptide antibody [6] and stained positive (blue)
with Stains-All stain [6,42] (data not shown). The
GRP94 multiplet was always present and qualita-
tively similar, regardless of the level of GRP94 ex-
pression, and was generated at both low and high
MOI, with both short and long periods of time post-
infection. The number of GRP94 isoforms observed
in some cases was as high as ¢ve; no attempt was
made to determine the conditions necessary to gen-
erate a higher number of forms, which was partly
dependent on resolution (Fig. 1B). The expression
level of each molecular-mass form was comparable,
except for the lowest mass form which was usually
present in signi¢cantly higher concentration.
Puri¢cation of the GRP94 multiplet by conven-
tional chromatographies led to a puri¢cation of all
forms of the GRP94 multiplet, indicating very sim-
ilar biochemical characteristics for the various mobi-
lity forms (Fig. 1A). Minor variations in elution were
seen for individual isoforms with Mono Q (anion-
exchange) chromatography, with higher-mobility
forms eluting at a lower salt concentration (Fig. 1C).
3.2. Glycosylation of native and recombinant GRP94
To determine whether GRP94 isoforms corre-
sponded to di¡erent levels of glycosylation, we
treated GRP94-infected Sf21 cells with tunicamycin,
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an inhibitor of N-linked glycosylation, and analyzed
the expressed proteins by SDS^PAGE. Treatments
with increasing concentrations of tunicamycin led
to increasing loss of higher molecular-weight forms
of GRP94 with an eventual reduction of all forms
into a single band at a position on SDS-gels lower
than even native GRP94 (Fig. 2A). To more directly
visualize the carbohydrate content of these protein
bands, samples were transferred to nitrocellulose
after SDS^PAGE, and then analyzed for Con A^
HRP binding. Visualization of Con A^HRP by
DAB substrate con¢rmed that all mobility forms
bound Con A, and that tunicamycin treatment re-
duced glycosylation to a point where the single
GRP94 form remaining no longer bound Con A.
This deglycosylated form of GRP94 migrated slightly
ahead of the native protein puri¢ed from dog heart,
which bound Con A and migrated with the lowest
glycosylated form seen in Sf21 cells. A qualitatively
similar e¡ect on GRP94 isoforms was produced by
treatment of puri¢ed GRP94 with Endo H (Fig. 2B).
These data are consistent with the predominant form
of GRP94 from dog heart containing a single site of
glycosylation, and that lower-mobility isoforms rep-
resent increasing amounts of glycosylation.
3.3. Phosphorylation of GRP94 in Sf21 cells
We have previously shown that GRP94 is among
several SR/ER Ca2-binding proteins that are e⁄-
ciently phosphorylated in vitro by protein kinase
CK2 [6]. To determine whether GRP94 was
phosphorylated in intact Sf21 cells, we carried out
metabolic labeling with 32Pi. Labeling of cells for
5 h led to the incorporation of phosphate into several
Fig. 2. GRP94 isoforms and carbohydrate content. (A) Sf21
cells were infected with recombinant baculovirus at an MOI of
10, then incubated for 48 h in the absence or presence of tuni-
camycin, as indicated. Cell homogenates (50 Wg) from separate
experiments, along with puri¢ed dog liver GRP94 (1 Wg), were
analyzed by SDS^PAGE and stained with Coomassie blue
(upper panel), or transferred to nitrocellulose (lower panel).
The nitrocellulose transfer was analyzed for Con A-binding
proteins using a Con A^HRP conjugate and DAB staining. (B)
Puri¢ed GRP94 was incubated in the absence (Control) or pres-
ence (Endo H) of 20 mU endoglycosidase H for 2 h at 37‡C.
Fig. 1. Expression and puri¢cation of a GRP94 multiplet in
Sf21 insect cells. Sf21 insect cells were infected with recombi-
nant baculovirus at an MOI of 10, then harvested after 2 days
of infection by solubilizing the cell pellet in a detergent and salt
solution as described in Section 2. The detergent extract was
absorbed onto DEAE-Sephacel and the elution, as well as sub-
sequent chromatographies, were carried out in the absence of
detergent. (A) Fractions from each step of the puri¢cation were
analyzed by SDS^PAGE and the gel stained with Coomassie
blue. Appearance of a GRP94 protein multiplet consisting of
3^5 molecular-mass isoforms on SDS-gels is indicated on the
right. H, 50 Wg cell homogenate; Tx, Triton X-100 (detergent)
extract from 50 Wg homogenate; DE, pooled fractions from
DEAE-Sephacel ; RQ, pooled fractions from Resource Q col-
umn (Pharmacia, FPLC); PhS, unbound protein fraction from
phenyl-Sepharose column; Molecular-weight standards are
shown on the left in kDa. (B) In some preparations, up to ¢ve
protein bands were easily visualized. Puri¢ed GRP94 isoforms
were partially fractionated by ion-exchange (Mono Q) chroma-
tography, with elution of lower-mobility forms (lane 1) eluting
slightly before higher-mobility forms (lane 2).
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proteins including a prominent protein band of ap-
proximately 95 kDa (Fig. 3, left panel). As it ap-
peared that this protein band migrated near the
monoglycosylated form of GRP94, we immunopreci-
pitated from the phosphorylated cell extract using
anti-GRP94 antibody and protein A-agarose. Immu-
noprecipitation veri¢ed that GRP94 was phosphory-
lated, but that phosphate incorporation occurred pri-
marily in a single phosphoprotein band migrating
with the monoglycosylated form of GRP94 (Fig. 3,
lane 2). Numerous experiments have veri¢ed this spe-
ci¢city, and have shown that phosphate was not as-
sociated with any form other than highest-mobility
form, presumably monoglycosylated GRP94.
To determine optimal conditions for GRP94 phos-
Fig. 3. Metabolic labeling of Sf21 cells. Sf21 cells were infected
at an MOI of 10 for 48 h, and infected cells were metabolically
labeled for 4 h using either [35S]methionine/cysteine or 32Pi.
Following labeling, cell pellets were extracted in bu¡er A. An
aliquot of the detergent extract was subjected to immunopreci-
pitation using puri¢ed anti-GRP94 antibodies; Extract and im-
munoprecipitates (IP) were analyzed by SDS^PAGE and auto-
radiography.
6
Fig. 4. E¡ects of postinfection time on metabolic labeling of GRP94. Sf21 cells were infected at an MOI of 1 under identical condi-
tions on three consecutive days, then all three dishes were metabolically labeled for 3 h using [35S]methionine/cysteine (¢rst panel) or
32Pi (second panel) on the third day. After labeling, cells were pelleted, extracted in detergent (bu¡er A), and subjected to immunopre-
cipitation. Immune complexes were analyzed by SDS^PAGE and autoradiography. A duplicate sample of immune complex from 32Pi-
labeled cells was washed under identical conditions, then resuspended in a phosphorylation reaction mixture containing puri¢ed 1 Wg
CK2 and 10 WM [Q-32P]ATP for 10 min at 37‡C (third panel). The autoradiogram shown in the second panel ([32P]phosphate) resulted
from ¢lm exposed for 16 h, whereas the ¢rst and third panels result from 5-h exposures. A Coomassie blue-stained gel is shown to in-
dicate total accumulated GRP94 protein (fourth panel).
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phorylation, we examined [32Pi] and [35S]methionine
labeling of GRP94 with increasing times postinfec-
tion. With increasing number of days postinfection,
levels of expressed GRP94 increased, as determined
by Coomassie blue staining (Fig. 4, fourth panel).
Note that all data in Fig. 4 result from immunopre-
cipitated GRP94 using identical volumes of puri¢ed
GRP94 antibody (IgG) added to equal volumes of
detergent extract. The large mass of GRP94 in the
immune complexes at 3 days postinfection, generally
contained reduced radiolabeled protein, i.e. rate of
synthesis of GRP94 did not directly correlate with
the amount of accumulated protein (Fig. 4, ¢rst
and fourth panels). The maximal rate of GRP94 syn-
thesis occurred in cells at 2 days postinfection,
whereas GRP94 accumulation was maximal at
3 days postinfection. Rates of GRP94 phosphory-
lation in situ, determined under the same experimen-
tal conditions, were similar to those of [35S]meth-
ionine incorporation, occurring maximally prior to
maximal GRP94 accumulation (Fig. 4, second pan-
el). Thus, higher levels of cellular GRP94 substrate
did not lead to higher rates of phosphorylation in
situ.
To verify that all GRP94 isoforms were phosphor-
ylatable in vitro, unlike that seen for the cellular
process, we immunoprecipitated GRP94 at each 24-
h postinfection period and phosphorylated it in vitro
using puri¢ed CK2 and [Q-32P]ATP (Fig. 4, third
panel). In contrast to the speci¢city observed in in-
tact cells, all glycosylated forms of GRP94 were sub-
strates for CK2 in vitro. (Note: the autoradiogram
shown in the second panel ([32P]phosphate) resulted
from ¢lm exposed for 16 h, whereas the ¢rst and
third panels result from 5 h exposures).
To further characterize GRP94 phosphorylation,
time courses of GRP94 labeling and decay of label
were examined. The data showed that an increase in
incorporation of radioactive label occurred with in-
creasing times of incubation for both 32Pi and
[35S]methionine (Fig. 5). In addition, measurements
of 32P and 35S radioactivity following a chase in la-
bel-free media indicated comparable decay rates for
each of the two types of labeled protein, in that
roughly half of each incorporated labels remaining
after a 5-h chase time. Although not as apparent in
this experiment, the pattern of glycosylation forms
was invariant during a 35S pulse-chase experiment.
A separate experiment looking at early chase times
illustrates this invariance more clearly (Fig. 5, lower
panel).
3.4. Phosphopeptide analyses of GRP94
phosphorylated in Sf21 cells or using CK2
To determine whether GRP94 phosphorylation in
intact cells occurred on CK2-sensitive sites, we car-
ried out one-dimensional phosphopeptide mapping
using the Cleveland procedure [43] (Fig. 6A). A sin-
gle major 18-kDa GRP94 phosphopeptide was gen-
erated by 0.1 U SAP that was indistinguishable for
GRP94 phosphorylated in intact Sf21 cells (Fig. 6A,
lanes 5 and 6), puri¢ed recombinant GRP94
phosphorylated by puri¢ed CK2 (Fig. 6A, lane 4),
and puri¢ed canine liver (Fig. 6A, lane 3) or canine
cardiac (Fig. 6A, lane 2) GRP94 phosphorylated by
puri¢ed CK2. Phosphopeptide maps for all other
phosphoproteins examined were distinct from that
of phospho-GRP94 samples (data not shown). The
characteristic map resulting from CK2-phosphorylat-
ed cardiac calsequestrin is shown for comparison
(Fig. 6Alane 1), and is also identical for in vitro
and in situ labeled protein [28,44]. Further veri¢ca-
tion that phosphorylation in intact cells occurred on
CK2-sensitive sites was carried out by comparing
Fig. 5. Time course of GRP94 pulse-labeling and pulse-chase.
Upper panel: Sf21 cells were infected at an MOI of 10 for
48 h, then metabolically labeled for 4, 8, or 12 h using
[35S]methionine/cysteine (35S) or 32Pi. Cells that were labeled for
8 h were spun down and washed free of label, then incubated
in label-free Grace’s media for 0, 2, or 5 h. At every time
point, cells were pelleted, extracted in detergent-containing bu¡-
er, and analyzed by SDS^PAGE and autoradiography. Lower
panel : A separate [35S]Met/Cys pulse-chase experiment more
clearly shows the invariance of GRP94 glycosylation pattern.
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[32P]phosphopeptides from cells with those generated
in vitro with CK2, following cleavage by trypsin or
papain (Fig. 6B).
To ascertain whether GRP94 attained a steady-
state level of phosphorylation in Sf21 cells, we mea-
sured GRP94 phosphorylation with or without prior
phosphatase pretreatment, using conditions of de-
phosphorylation which were su⁄cient to remove
32Pi from CK2-labeled sites. After 40 min of subse-
quent phosphorylation by CK2, Pi incorporation
into dephosphorylated GRP94 was increased by ap-
proximately 0.2 mol/mol GRP94 compared to con-
trol treated, indicating a steady-state level of
phosphorylated GRP94 in the Sf21 cells (Fig. 7).
The increase in 32P incorporation appeared to occur
primarily, if not exclusively, in the lowest molecular
weight isoform of GRP94 (Fig. 7, inset), suggesting
that the selective phosphorylation of this isoform
during metabolic labeling correlates with the
steady-state levels in the mature protein. Phospho-
peptide (SAP) maps of phospho-GRP94 with and
without phosphatase pretreatment gave identical pat-
Fig. 6. Phosphopeptide mapping of phospho-GRP94 samples. Radioactively phosphorylated GRP94 was generated from various sam-
ples, electrophoresed in SDS gels, and excised from dried gels. (A) Gel pieces containing [32P]GRP94 were placed in wells of a second
SDS-gel (15% acrylamide) and cleaved during electrophoreses at 5^10 mA by Staphylococcus aureus protease (0.1 U) according to the
method of Cleveland et al. [43]. The resulting one-dimensional [32P]phosphopeptide map was visualized by autoradiography. Phosphor-
ylated protein bands correspond to four protein samples phosphorylated in vitro using puri¢ed CK2; lane 1, cardiac calsequestrin
(CSQ); lane 2, native GRP94 from canine heart; lane 3, native GRP94 from canine liver; and lane 4, baculovirus-generated GRP94
in Sf21 cells ; and two GRP94 samples phosphorylated metabolically in intact Sf21 cells, in the absence or presence of 0.3 WM gel-
danamycin (lanes 5 and 6, respectively). (B) Gel pieces containing [32P]GRP94 from radiolabeled Sf21 cells (C) or produced by phos-
phorylation of the pure protein (P) by CK2 were processed for cleavage using 0.3 Wg of trypsin or papain as described under Section
2. Samples were proteolyzed at 37‡C for 2 h, and aqueous contents were analyzed by SDS^PAGE (15% acrylamide). Peptide-contain-
ing gels were dried without ¢xation, and autoradiography performed. Mobilities of molecular-mass (Mr) standards and dye front are
as indicated.
Fig. 7. E¡ects of phosphatase pretreatment on GRP94 phos-
phorylation by protein kinase CK2. GRP94 puri¢ed from Sf21
cells (cf. Fig. 1) was preincubated for 30 min at 30‡C in 30 mM
MES (pH 5.8), 0.1% Triton X-100, and 3 mM EGTA in the
absence (Control) or presence (+PPase) of 0.5 U/ml of acid
phosphatase. Aliquots of pretreated GRP94 were subjected to a
standard in vitro phosphorylation reaction using CK2 at pH
7.4 for the indicated times.
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terns suggesting that endogenous phosphate resides
on CK2-sensitive sites (data not shown).
3.5. E¡ects of drug treatments
The slow time course of 32P incorporation and
decay suggested that GRP94 phosphorylation might
occur in conjunction with or immediately following
GRP94 translation. To determine whether GRP94
biosynthesis and phosphorylation were temporally
related processes, we tested whether inhibition of
protein synthesis by cycloheximide would reduce
GRP94 phosphorylation. GRP94 biosynthesis as de-
termined by [35S]Met/Cys levels was inhibited by
about 75% at 5 Wg/ml, and by 90% at 50 Wg/ml cyclo-
heximide (Fig. 8A). GRP94 phosphorylation, on the
other hand, was not substantially inhibited, with
only a 10% decrease observed using 50 Wg/ml cyclo-
heximide. Inhibition of newly synthesized GRP94 did
not produce any alteration in the pattern of GRP94
glycosylation seen with protein stain, consistent with
pulse-chase data in showing that GRP94 glycosyla-
tion isoforms were not transient forms.
Because GRP94 cycling between the ER and cis^
Golgi complex can be disrupted by brefeldin A or
microtubule-disrupting agents [45], we tested the ef-
fects of these drugs on GRP94 hyperglycosylation
and phosphorylation in Sf21 cells. Addition of 20
Wg/ml brefeldin A or 1.0 Wg/ml nocadazole to cells
during a 6 h labeling did not signi¢cantly a¡ect
GRP94 phosphorylation (Fig. 8B), nor had any ef-
fect on GRP94 hyperglycosylation (data not shown).
Thapsigargin (5 WM), an agent that can deplete ER
Ca2 levels by inhibition of SR/ER Ca2-ATPase
[46], was also without e¡ect, although a general de-
crease in constitutive phosphorylation was routinely
observed, not speci¢c for GRP94. GRP94 phosphor-
ylation was also not a¡ected by treatment of Sf21
Fig. 8. E¡ects of drug treatments on GRP94 phosphorylation in intact Sf21 cells. (A) Sf21 cells were infected at an MOI of 10 for
48 h, and infected cells were metabolically labeled for 6 h using [35S]Met/Cys or 32Pi. under control conditions (0), or with increasing
concentrations of cycloheximide (5, 10, or 20 Wg/ml). Cell extracts (50 Wg) were analyzed by SDS^PAGE and stained with Coomassie
blue (lower panel) and autoradiography (upper panel). (B) Cells were metabolically labeled for 6 h using 32Pi under control conditions
(C), or with addition of 5 WM thapsigargin (Thg), 20 Wg/ml brefeldin A (BfA) or 1.0 Wg/ml nocadazole (Noc). After labeling, cells
were pelleted, extracted in bu¡er A, and analyzed by SDS^PAGE and autoradiography.
Fig. 9. Metabolic labeling of GRP94 and cardiac calsequestrin
in Sf21 cells. Sf21 cells were infected with recombinant baculo-
viruses encoding either canine GRP94 or canine cardiac calse-
questrin at an MOI of 10 for 48 h; cells were then metabol-
ically labeled for 6 h using [35S]Met/Cys or 32Pi. under control
conditions (3), or (+) in 10 WM hydrogen peroxide. Cell homo-
genates were analyzed by SDS^PAGE and autoradiography.
Only the center portion of the autoradiogram is shown to ac-
centuate the radioactive bands corresponding to GRP94 and
calsequestrin (CSQ).
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cells with 0.5 Wg/ml tunicamycin or 3 WM geldana-
mycin added during a 5-h labeling pulse (data not
shown). Geldanamycin has been shown to bind di-
rectly to GRP94 leading to dissociation of GRP94^
protein complexes [47].
Because cardiac calsequestrin has previously been
shown to be exclusively phosphorylated on CK2-sen-
sitive sites in intact cardiac tissue [26], we investi-
gated whether calsequestrin, like GRP94, was consti-
tutively phosphorylated in intact Sf21 cells (Fig. 9).
Incorporation of 32P was also localized exclusively to
CK2-sensitive sites as previously determined by
phosphopeptide mapping [44]. Incubation of cells
with 20 WM hydrogen peroxide, a treatment previ-
ously shown to inhibit protein biosynthesis in rat
luteal cells [48] led to a nearly complete inhibition
of GRP94 and calsequestrin biosynthesis, but had
only a minor e¡ect on phosphorylation, in accor-
dance with the e¡ects of cycloheximide.
4. Discussion
These studies of GRP94 biosynthesis and metabo-
lism in Sf21 cells demonstrate a complex cell biology
in which GRP94 is hyperglycosylated as well as
phosphorylated on sites which are phosphorylated
in vitro by protein kinase CK2. Hyperglycosylated
GRP94 was an invariable feature of its overexpres-
sion in Sf21 cells, producing comparable steady-state
levels for each of several GRP94 isoforms in SDS-
gels. Phosphorylation did not, however, occur simi-
larly for all, being exclusively seen on the highest
mobility form. Our data support a view of two dis-
tinct cellular pathways for GRP94 leading to two
sets of distinct protein modi¢cations.
Phosphorylation of high-mobility GRP94 in Sf21
cells was constitutive, occurring in the absence of
hormone stimulation, and increasing as a function
of time. 32P-labeled sites on GRP94 in intact Sf21
cells were the same as those phosphorylated by pro-
tein kinase CK2 in vitro, based on proteolytic phos-
phopeptide mapping using three di¡erent proteases.
Phosphorylation of GRP94 in NRK cells has previ-
ously been observed in metabolically labeled NRK
cells by Ramakrishnan et al. [49]. This GRP94 kinase
exhibited properties in vitro expected of CK2, as well
as properties perhaps unexpected, leading those au-
thors to conclude that a novel ‘94-kinase’ activity
was responsible for phosphorylation in NRK cells.
This study, however, did not compare phosphopep-
tide maps resulting from 94-kinase with that of CK2-
phosphorylated GRP94, leaving unanswered the
question of whether CK2 was involved. Csermely et
al. [50] reported that GRP94 underwent autophos-
phorylation on sites distinct from CK2-sensitive sites.
Using their same conditions, we did not observe sig-
ni¢cant phosphorylation of puri¢ed GRP94 in the
absence of added CK2 (data not shown).
Protein kinase CK2 is emerging as a major e¡ector
of protein targetting within the secretory pathway by
phosphorylating membrane proteins on cytosolic or
lumenal sites. Phosphorylation by CK2 of several
transmembrane proteins on cytosolic sites is believed
to a¡ect subcellular sorting by leading to the recruit-
ment of adaptor proteins (AP-1 or AP-2) for subse-
quent formation of clathrin-coated vesicles. Such a
CK2 determinant has been described for lysosomal
resident and sorting proteins such as mannose-6-
phosphate receptor [51], lamp-1 [52], Gp95/sortillin
[53], as well as for the varicella-zoster virus glycopro-
tein I [54]. A determinant for trans^Golgi localiza-
tion involving phosphorylation by CK2 has also
been described for the Golgi resident protease furin
[55]. Wan et al. [55] have de¢ned a cytosolic factor
PACS-1 which binds to AP-1 and to several of these
CK2 substrates, and may play a central role in cou-
pling CK2 phosphorylation to the clathrin-sorting
machinery. Meanwhile, CK2 phosphorylation of
the human immunode¢ciency virus HIV-1 protease
Vpu results in transport of Vpu-bound CD4 mole-
cules back to the ER where they are subsequently
proteolyzed [56].
Many laboratories have also reported the phos-
phorylation of proteins by a CK2-like activity within
ER or Golgi lumens. Sfeir and Veis [57,58] have
reported that lumenal ER-localized CK2 activity re-
sults in secretion of highly phosphorylated phosphor-
phoryns into extracellular complexes. ER-phosphor-
ylation of lumenally exposed CK2-sensitive sites has
also been reported for interleukin-6 [59], and for cy-
tomegalovirus envelope protein gB which results in
phospho-900Ser exposed to extracellular space [60].
Golgi-localized CK2-like phosphorylation is perhaps
best known for the phosphorylation of the secreted
proteins casein [61,62] and osteopontin [63], which
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accumulate high levels of phosphate on CK2-sensi-
tive sites. Lumenal Golgi phosphorylation on CK2-
sensitive sites has also been reported for rat pancre-
atic bile salt-dependent lipase [64], apolipoprotein B
[65], and for the resident Golgi protein sialyltransfer-
ase [66]. In the case of lipase, Pasqualini et al. [64]
showed that CK2 phosphorylation in a late-Golgi
compartment was required for secretion.
We have previously established that cardiac calse-
questrin, a well-characterized lumenal SR protein in
heart cells, undergoes active phosphorylation on
CK2-sensitive sites in vivo [26]. Fractionation of car-
diac microsomes following active calcium oxalate
loading led to the identi¢cation of a non-SR (pre-
sumably non-ER) localization of calsequestrin kinase
(CK2) activity [6,26], consistent with a phosphory-
lation event occurring prior to junctional SR deposi-
tion of calsequestrin. Chromatographic fractionation
and puri¢cation of the calsequestrin kinase from
heart tissue produced single peaks of calsequestrin
kinase activity which co-puri¢ed with CK2 activity
assayed by a CK2-speci¢c substrate, and was highly
enriched in anti-CK2K immunoreactivity [26]. CK2
in cardiac microsomes required permeabilizing con-
centrations of detergent to a¡ect phosphorylation of
added substrate [6], further supporting an intralume-
nal localization.
Pinna and co-workers [67] have shown that a Gol-
gi-localized CK2 activity exhibits minor di¡erences
in peptide sequence speci¢city from CK2 isolated
from cytoplasm, however, recent studies from Pas-
qualini et al. [64] suggest that the Golgi-localized
CK2 activity result from bona ¢de CK2. That con-
clusion is also supported by studies in which CK2 is
found in extracellular matrix [68], or attached to the
outer membrane of cells where it can be released by
addition of CK2 substrates [69]. Nevertheless, a
mechanism by which normally cytosolic CK2 might
localize to membrane lumens remains to be deter-
mined, although some speculation exists [69].
Phosphorylation of GRP94 in ER compartments
of Sf21 cells would also seem to require an ER-lo-
calized CK2 or CK2-like activity. An alternative ex-
planation for GRP94 phosphorylation on CK2-sen-
sitive sites would be for GRP94 to undergo reverse
translocation from the ER to the cytosol, where it
would be phosphorylated by soluble kinase. The pro-
cess of reverse translocation, however, is predicted to
result in subsequent degradation by proteasomal en-
zymes [70], a process that is not indicated by our
pulse-chase measurements. Moreover, GRP94 accu-
mulation, glycosylation patterns, and phosphory-
lation were not a¡ected by treatments with 20 WM
lactacystin or 20 WM MG-132, speci¢c inhibitors of
proteasomes (data not shown). While future studies
must determine whether currently known CK2 iso-
forms are responsible for such ER/Golgi phosphory-
lation reactions, the selectivity of resident ER/SR
proteins for phosphorylation by CK2 in vitro, the
active nature of this reaction for the resident SR
protein cardiac calsequestrin in Sf21 cells and in
vivo, and the speci¢city of phosphorylation observed
here for GRP94, indicate a possible physiological
role for this reaction on resident ER/SR proteins.
Hyperglycosylation of GRP94 represents an inter-
esting and unique aspect of GRP94 cell biology.
While two previous studies in mammalian cells
have also observed GRP94 heterogeneity on SDS-
gels, our data corroborate the conclusions of Qu et
al. [32] that GRP94 heterogeneity in results from
alternative, endoglycosidase H sensitive, glycosyla-
tion processes. Nonetheless, GRP94 glycosylation
patterns in Sf21 insect cells were di¡erent from those
described by Qu et al. [32] in some signi¢cant re-
spects. First, our data indicate that up to ¢ve of
the six potential sites [32] were modi¢ed (cf. Fig.
1B). Each form displayed a unique mobility, and
all forms were simultaneously present and stably ex-
pressed under all conditions and times; not consis-
tent with hyperglycosylation being expression-level
dependent, but perhaps suggestive of a sequential
mechanism of recurrent and increasing glycosylation.
Another signi¢cant di¡erence between our data and
that described by Qu et al. [32] is that greater degrees
of GRP94 glycosylation did not occur in an all-or-
none fashion. On the contrary, GRP94 forms con-
taining increasing levels of carbohydrate were always
resolved as a multiplet, indicating that stable inter-
mediate levels were achieved. This observation is
similar to those made by Feldweg and Srivastava
[33] for native GRP94 from mouse sarcomas. Thus,
a cellular mechanism must account for accumula-
tions of each glycosylation level, suggesting sequen-
tial ‘rounds’ of glycosylation. Such a process of con-
secutive glycosylation might occur during the
retrieval of GRP94 from Golgi compartments by
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the KDEL receptor [71], or from the plasma mem-
brane [14,15,72]. GRP94 has been previously shown
to move to the cell surface as part of a macromolec-
ular complex [14], and a retrograde pathway exists
for KDEL-containing proteins from the plasma
membrane to the ER which allows for a fully folded
protein to undergo N-glycosylation [72]. In any case,
the process responsible for sequential glycosylation is
not evident from the literature. Whether it is unique
to GRP94, whether it results from cyclical ER transit
and retention, and whether it a¡ects GRP94 biology,
will await further studies.
The baculovirus^insect cell system is used rou-
tinely for foreign glycoprotein production; nonethe-
less, the N-glycosylation pathways in these cells ex-
hibit known di¡erences from mammalian cells. The
primary di¡erences appear to be in terminal modi¢-
cations of glycans that acquire outer-chain sialic acid
or galactose, typical of proteins that proceed to distal
points in the secretory pathway [73]. Marchal et al.
[74] determined that the processing pathway paral-
leled the mammalian cell pathway up to the point at
which Golgi-localized hexosaminidase activities
sometimes resulted in shortened chains. Thus, high-
mannose glycans typical of resident ER proteins are
expected to be similar or identical to those generated
in mammalian cells, as are sites of carbohydrate
modi¢cation. In the case of the resident ER protein
calreticulin, Denning et al. [75] showed that co-trans-
lational signal peptide cleavage and posttranslational
N-linked glycosylation appeared the same in human
and insect cells. Nonetheless, future studies will need
to verify identical sites of glycosylation and glycan
structures of GRP94 in mammalian and insect cells.
In conclusion, the selective nature of the carbohy-
drate processing, the ability to accumulate signi¢cant
levels of GRP94 pools with increasingly greater levels
of carbohydrate, and the selective nature of the phos-
phorylation, point to a highly compartmentalized
process for GRP94 phosphorylation and hyperglyco-
sylation in eukaryotic cells. These novel features of
GRP94 processing add to an already interesting and
diverse role in ER/SR compartments.
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